Trial Outcomes & Findings for Pudendal Enhancement of Enhanced Recovery After Surgery (ERAS) for Reconstructive Surgery (PEERS) (NCT NCT04171050)
NCT ID: NCT04171050
Last Updated: 2025-06-03
Results Overview
Measured in morphine milligram equivalents (MME) at 24 hours
COMPLETED
PHASE4
44 participants
24 hours after surgery
2025-06-03
Participant Flow
Participant milestones
| Measure |
Group 1: Local Anesthesia
Standard of care with local anesthesia used during surgery
Local anaesthetic: Local anesthesia injections
|
Group 2: Local Anesthesia Plus Pudendal Nerve Block
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery
Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
|
|---|---|---|
|
Overall Study
STARTED
|
22
|
22
|
|
Overall Study
COMPLETED
|
21
|
21
|
|
Overall Study
NOT COMPLETED
|
1
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Pudendal Enhancement of Enhanced Recovery After Surgery (ERAS) for Reconstructive Surgery (PEERS)
Baseline characteristics by cohort
| Measure |
Group 1: Local Anesthesia
n=22 Participants
This group was assigned usual care, which involved local anesthesia administered per surgeon preference
|
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery
Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
|
Total
n=44 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
63 years
n=5 Participants
|
66 years
n=7 Participants
|
65 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
22 Participants
n=5 Participants
|
22 Participants
n=7 Participants
|
44 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White
|
18 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
34 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Other
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Refused to answer
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
22 participants
n=5 Participants
|
22 participants
n=7 Participants
|
44 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 24 hours after surgeryMeasured in morphine milligram equivalents (MME) at 24 hours
Outcome measures
| Measure |
Group 1: Local Anesthesia
n=22 Participants
Standard of care with local anesthesia used during surgery
Local anaesthetic: Local anesthesia injections
|
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery
Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
|
|---|---|---|
|
Narcotic Use
|
8 MME
Interval 0.0 to 20.0
|
6.75 MME
Interval 0.0 to 15.0
|
PRIMARY outcome
Timeframe: 48 hours after surgeryMeasured in MME at 48 hours
Outcome measures
| Measure |
Group 1: Local Anesthesia
n=22 Participants
Standard of care with local anesthesia used during surgery
Local anaesthetic: Local anesthesia injections
|
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery
Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
|
|---|---|---|
|
Narcotic Use
|
8 MME
Interval 0.0 to 26.0
|
7 MME
Interval 0.0 to 35.0
|
SECONDARY outcome
Timeframe: 0-2 hours, 2-4 hours, 4-8 hours, 8-12 hours, 24 hours, and 48 hours after surgeryPopulation: Patients were not present for 8-12 hour assessment (outpatient surgery so they were sent home)
Average pain score by Numerical Rating Scale (NRS). The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain).
Outcome measures
| Measure |
Group 1: Local Anesthesia
n=22 Participants
Standard of care with local anesthesia used during surgery
Local anaesthetic: Local anesthesia injections
|
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery
Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
|
|---|---|---|
|
Pain Scores
0-2 hours
|
1.2 score on a scale
Standard Deviation 1.8
|
1.6 score on a scale
Standard Deviation 2.4
|
|
Pain Scores
48 hours
|
3 score on a scale
Standard Deviation 2
|
4 score on a scale
Standard Deviation 3
|
|
Pain Scores
2-4 hours
|
1.4 score on a scale
Standard Deviation 1.7
|
1.1 score on a scale
Standard Deviation 1.8
|
|
Pain Scores
4-8 hours
|
1.9 score on a scale
Standard Deviation 1.8
|
1.4 score on a scale
Standard Deviation 2.0
|
|
Pain Scores
24 hours
|
4 score on a scale
Standard Deviation 2
|
3 score on a scale
Standard Deviation 3
|
SECONDARY outcome
Timeframe: 6 weeks after surgeryDays to return to normal activity, defined as walking, sitting, and performing daily household tasks comfortably. Upon discharge, all participants received a diary to record the date they returned to normal daily activities. Participants were contacted at 2 and 6 weeks postoperatively either by telephone or during their scheduled office visit and were asked about their time to return to normal activity.
Outcome measures
| Measure |
Group 1: Local Anesthesia
n=22 Participants
Standard of care with local anesthesia used during surgery
Local anaesthetic: Local anesthesia injections
|
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery
Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
|
|---|---|---|
|
Return to Normal Daily Activities
|
10 Days
Interval 6.0 to 18.0
|
10 Days
Interval 7.0 to 11.0
|
SECONDARY outcome
Timeframe: 48 hours after surgery, 2 weeks after surgeryPopulation: Participants who completed the study, per Participant Flow.
Satisfaction with postoperative pain control was assessed using a verbal scale of 1=very satisfied, 2=Somewhat satisfied, 3=Neither satisfied nor dissatisfied, 4=Somewhat dissatisfied, 5=very dissatisfied
Outcome measures
| Measure |
Group 1: Local Anesthesia
n=21 Participants
Standard of care with local anesthesia used during surgery
Local anaesthetic: Local anesthesia injections
|
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=21 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery
Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
|
|---|---|---|
|
Patient Satisfaction With Postoperative Recovery
5 - at 2 weeks
|
2 Participants
|
1 Participants
|
|
Patient Satisfaction With Postoperative Recovery
Not obtained at 2 weeks
|
2 Participants
|
0 Participants
|
|
Patient Satisfaction With Postoperative Recovery
1 - at 48 hours
|
16 Participants
|
13 Participants
|
|
Patient Satisfaction With Postoperative Recovery
1 - at 2 weeks
|
15 Participants
|
17 Participants
|
|
Patient Satisfaction With Postoperative Recovery
2 - at 2 weeks
|
0 Participants
|
2 Participants
|
|
Patient Satisfaction With Postoperative Recovery
3 - at 2 weeks
|
2 Participants
|
0 Participants
|
|
Patient Satisfaction With Postoperative Recovery
4 - at 2 weeks
|
0 Participants
|
1 Participants
|
|
Patient Satisfaction With Postoperative Recovery
2 - at 48 hours
|
3 Participants
|
4 Participants
|
|
Patient Satisfaction With Postoperative Recovery
3 - at 48 hours
|
0 Participants
|
1 Participants
|
|
Patient Satisfaction With Postoperative Recovery
4 - at 48 hours
|
0 Participants
|
2 Participants
|
|
Patient Satisfaction With Postoperative Recovery
5 - at 48 hours
|
1 Participants
|
0 Participants
|
|
Patient Satisfaction With Postoperative Recovery
Not obtained at 48 hours
|
1 Participants
|
1 Participants
|
SECONDARY outcome
Timeframe: Tracked by hour through time of patient discharge (up to 72 hours)Tracked in hours
Outcome measures
| Measure |
Group 1: Local Anesthesia
n=22 Participants
Standard of care with local anesthesia used during surgery
Local anaesthetic: Local anesthesia injections
|
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery
Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
|
|---|---|---|
|
Length of Hospital Stay
|
16.5 Hours
Interval 4.5 to 24.0
|
9 Hours
Interval 5.0 to 23.0
|
Adverse Events
Group 1: Local Anesthesia
Group 2: Local Anesthesia Plus Pudendal Nerve Block
Serious adverse events
| Measure |
Group 1: Local Anesthesia
n=22 participants at risk
Standard of care with local anesthesia used during surgery
Local anaesthetic: Local anesthesia injections
|
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 participants at risk
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery
Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
|
|---|---|---|
|
General disorders
hospital readmission
|
0.00%
0/22 • 6 weeks postoperatively
|
4.5%
1/22 • Number of events 1 • 6 weeks postoperatively
|
Other adverse events
| Measure |
Group 1: Local Anesthesia
n=22 participants at risk
Standard of care with local anesthesia used during surgery
Local anaesthetic: Local anesthesia injections
|
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 participants at risk
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery
Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
|
|---|---|---|
|
Surgical and medical procedures
Pudendal nerve entrapment
|
0.00%
0/22 • 6 weeks postoperatively
|
4.5%
1/22 • Number of events 1 • 6 weeks postoperatively
|
|
General disorders
Postoperative nausea
|
4.5%
1/22 • Number of events 1 • 6 weeks postoperatively
|
0.00%
0/22 • 6 weeks postoperatively
|
|
Injury, poisoning and procedural complications
Anesthetic complication
|
4.5%
1/22 • Number of events 1 • 6 weeks postoperatively
|
0.00%
0/22 • 6 weeks postoperatively
|
|
Renal and urinary disorders
Urinary retention at 48hr
|
18.2%
4/22 • Number of events 4 • 6 weeks postoperatively
|
27.3%
6/22 • Number of events 6 • 6 weeks postoperatively
|
Additional Information
Tamara Grisales, MD
University of California, Los Angeles
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place